HARVARD SCIENTIFIC CORP
NT 10-Q, 2000-11-14
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: CELERITY SYSTEMS INC, 10QSB, EX-27, 2000-11-14
Next: ONYX ACCEPTANCE CORP, 10-Q, 2000-11-14




                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                   FORM 12b-25

                         Commission File Number 0-27599

                           Notification of Late Filing

                                  (Check One):

   [ ] Form  10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-QSB  [ ] Form N-SAR
     For Period Ended: September 30, 2000
     [ ]  Transition Report on Form  10-K
     [ ]  Transition Report  on Form  20-F
     [ ]  Transition Report on Form 11-K
     [ ]  Transition Report  on  Form  10-Q
     [ ]  Transition Report on Form N-SAR
     For the Transition Period Ended:



Nothing  in this  form  shall be  construed  to imply  that the  Commission  has
verified any information contained herein.

If the notification  relates to a portion of the filing checked above,  identify
the Item(s) to which the notification relates:

                         Part I - Registrant Information

                     Full Name of Registrant HARVARD SCIENTIFIC CORP.

                           Former Name if Applicable:

              1325 Airmotive Way, Suite 125, Reno, NV 89502
            Address of Principal Executive Office (Street and Number)







<PAGE>




                        Part II - Rules 12b-25(b) and (c)

         If the subject report could not be filed without unreasonable effort or
expense  and  the  registrant  seeks  relief  pursuant  to Rule  12b-25(b),  the
following should be completed. (Check box if appropriate)

[X]      (a) The reasons described in reasonable detail in Part III of this form
         could not be eliminated without unreasonable effort or expense;

[X]      (b) The subject annual report, semi-annual report, transition report on
         Form 10-K,  Form 20-F,  11-K or Form N- SAR, or portion thereof will be
         filed on or before the fifteenth  calendar day following the prescribed
         due date; or the subject  quarterly report or transition report on Form
         10-QSB,  or  portion  thereof  will be filed  on or  before  the  fifth
         calendar day following the prescribed due date; and

[X]     (c)  The  accountant's  statement  or  other  exhibit  required  by Rule
        12b-25(c) has been attached if applicable.

                              Part III - Narrative

         State below in reasonable detail the reasons why Form 10-K, 20-F, 11-K,
10-QSB,  N-SAR,  or the transition  report or portion  thereof could not be file
within the prescribed period.

                  The  Company's  independent  accountant  has not completed its
review of the Company's financial statements.

                           Part IV - Other Information

         (1) Name and  telephone  number of person to contract in regard to this
notification.

            Curtis A. Orgill          775             323-7122
                (Name)             (Area Code)     (Telephone Number)

         (2) Have all other periodic  reports required under section 13 or 15(d)
of the Securities  Exchange Act of 1934 or section 30 of the Investment  Company
Act of 1940 during the  preceding 12 months or for such shorter  period that the
registrant was required to file such report(s) been filed?  If the answer is no,
identify report(s).

                                                                [X] Yes   [ ] No

         (3) Is it  anticipated  that  any  significant  change  in  results  of
operations  from the  corresponding  period  for the last  fiscal  year  will be
reflected by the  earnings  statements  to be included in the subject  report or
portion thereof?

                                                                 [] Yes   [X] No

         If  so:  attach  an  explanation  of  the  anticipated   change,   both
narratively and  quantitatively,  and, if  appropriate,  state the reasons why a
reasonable estimate of the results cannot be made.

                            HARVARD SCIENTIFIC CORP.
                  (Name of Registrant as specified in charter)

has  caused  this  notification  to be signed on its  behalf by the  undersigned
thereunto duly authorized.


Date:   November 14, 2000                   By: /s/ Curtis A. Orgill
                                                --------------------
                                                    Curtis A. Orgill,
                                                    Chief Executive Officer

                                        2



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission